Immunotherapy in COVID-19: why, who, and when?

Sinha, Pratik; Calfee, Carolyn S

Sinha, Pratik; Calfee, Carolyn S.

Sinha P; Division of Clinical and Translational Research and Division of Critical Care, Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 63110, USA. Electronic address: p.sinha@wustl.edu.
Calfee CS; Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.

Lancet Respir Med ; 9(6): 549-551, 2021 06.

Article in English | MEDLINE | ID: covidwho-1233649

Subject(s)

COVID-19; Humans; Immunologic Factors; Immunotherapy; Receptors, Interleukin-6; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google